Alliance with AstraZeneca is CAT #39;s whiskers for biotech firm UK biotechnology company Cambridge Antibody Technology has announced a five-year alliance with pharmaceutical giant AstraZeneca. CAT said AstraZeneca will make an upfront equity investment in CAT worth 75 